
Critinem 250mg/250mg Injection
Marketer
Novartis India Ltd
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Critinem 250mg/250mg Injection
Combiflox 250 mg/250 mg Injection is a dual-antibiotic formulation indicated for treating serious bacterial infections. This medication combats infectious agents, thereby limiting infection spread. Administration of Combiflox 250 mg/250 mg Injection must be overseen by a medical professional. Adherence to the prescribed treatment schedule is crucial; complete the full course, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions, such as redness, swelling, and pain, may also occur but usually resolve. Report any worsening side effects to your physician promptly. Seek immediate medical attention for allergic reactions (skin rashes, itching, swelling, breathing difficulties, etc.). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Critinem 250mg/250mg Injection
Life-threatening bacterial infestations
Major Benefits of Critinem 250mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Critinem 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Critinem 250mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Critinem 250mg/250mg Injection works:
Each Critinem 250 mg/250 mg injection contains imipenem, an antibiotic, and cilastatin, a dehydropeptidase I inhibitor. Imipenem combats bacterial infections by disrupting the formation of their protective cell walls, a process vital for bacterial survival. Cilastatin safeguards imipenem from degradation by dehydropeptidase I, thereby extending its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Critinem 250 mg/250 mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Critinem 250 mg/250 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Critinem 250 mg/250 mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm from the medication.
DrivingUNSAFE
Administering Critinem 250 mg/250 mg Injection can induce adverse reactions potentially impairing driving capabilities. Certain drug-related side effects, including hallucinations (visual, auditory, or sensory), may compromise safe driving in susceptible individuals.
KidneyCAUTION
For individuals with impaired kidney function, administration of Critinem 250 mg/250 mg Injection requires careful monitoring. Dosage modification of Critinem 250 mg/250 mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Critinem 250 mg/250 mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Critinem 250mg/250mg Injection :
Should you forget a dose of Critinem 250 mg/250 mg Injection, seek your physician's advice.
Facts to Know About Critinem 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
